Treatment for chronic (myelopathy) and acute spinal cord injury.

Diagnosis and treatment of repetative neuro-trauma

Development and use of new imaging techniques to improve surgical and nonsurgical treatment of cervical spinal disorders (spinal stenosis, spondylosis, and herniated discs)

Use of minimally-invasive principles/techniques to improve cervical and lumbar spine surgery

Outcomes research to help evaluate and improve current spine surgical procedures.

Spine surgery guidelines development.

Diagnosis of mild traumatic brain injury (mTBI) including concussions and subconcusive injuries.

CSM-S Trial
National expert member (one of 20). The expert panel evaluates the patients being entered into the trial to establish clinical equipoise. The CSM-S trial is a prospective randomized multicenter trial evaluating clinical and socioeconomic outcome following anterior versus posterior surgical intervention for CSM.

Pfizer STRIVE Trial
Mount Sinai Principal Investigator for STRIVE Trial, a multicenter trial designed to test the efficacy and safety of a vaccine to help prevent infection in people undergoing multi-level spinal fusion surgery.

StemCells Pathway Trial: Mount Sinai
Co-investigator and member of surgical team. The Pathway Trial is designed to test the efficacy and safety of stem cell injection on patients with AIS, A, B, and C chronic spinal cord injury.

InVivo 100-101 Trial: Mount Sinai
Co-investigator on the InVivo 100-101 Trial, which is designed to test the safety of a Scaffold device on patients with complete AIS A acute spinal cord injury.

Vertex VX-210 Trial: Mount Sinai
Co-investigator on the VX-210 Trial, which is designed to test the efficacy and safety of the VX-210 drug on patients with AIS A or B acute spinal cord injury.